跳至主要内容
临床试验/NCT06068348
NCT06068348进行中(未招募)不适用

Collection of Human Blood for Development of Liquid Biopsy Assay

University of Central Florida1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年10月7日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
60
试验地点
1
主要终点
To determine if the biomarker, Chaperonin-Containing TCP-1 (CCT), can be used to detect circulating tumor cells (CTC) in blood.

研究概览

简要总结

The purpose of this study is to develop a liquid biopsy approach for detection of circulating tumor cells (CTC) that could be used in place of the more invasive and potentially risky methods of tissue biopsy. The aims of the project are: (a) determine whether the Chaperonin-Containing TCP-1 (CCT) chaperonin can used to identify rare cancer cells in blood, and (b) establish whether the cancer cells detected using the CCT chaperonin for identification have invasive or metastatic potential.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female
  • Age greater than or equal to 18 and less than or equal to 80 years.

排除标准

  • Adults unable to give informed consent
  • Individuals who are not yet adults (infants, children, teenagers; under the age of 18)
  • Individuals who weigh less than 110 lbs (as standard clinically advised to not give blood)
  • Pregnant women (due to hormonal changes in blood)
  • Prisoners
  • Persons reporting a current microbial (bacterial, viral, or fungal) infections
  • Persons reporting that they are current taking antibiotic medications
  • Persons with body temperatures above 99oF (indicating a fever)

结局指标

主要结局

To determine if the biomarker, Chaperonin-Containing TCP-1 (CCT), can be used to detect circulating tumor cells (CTC) in blood.

时间窗: 3 years

次要结局

  • To determine if the CCT chaperonin can provide information on the metastatic potential of CTC.(3 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Liquid Biopsy Collection Study | 临床试验